Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab
Phase 4
Completed
- Conditions
- First Posted Date
- 2007-08-02
- Last Posted Date
- 2009-04-10
- Lead Sponsor
- Probity Medical Research
- Target Recruit Count
- 50
- Registration Number
- NCT00510536
- Locations
- 🇨🇦
K. Papp Clinical Research Inc., Waterloo, Ontario, Canada
© Copyright 2024. All Rights Reserved by MedPath